About [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate (PubChem CID 174296618) has the molecular formula C38H44N6O8S2
and a molecular weight of 776.94 g/mol. Its IUPAC name is [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate.
Frequently Asked Questions
What is the IUPAC name of [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate?
The IUPAC name of [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate (CID 174296618) is [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate.
What is the SMILES notation for [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate?
The canonical SMILES for [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate is CCc1c2c(nc3ccc(OC(=O)N4CCN(C(=O)CCC(=O)N5CCN(C)CC5)C5CSSCC54)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.
What is the InChIKey of [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate?
The InChIKey is CPTYWPVVLXVKKY-XFYOYBLZSA-N. The full InChI is InChI=1S/C38H44N6O8S2/c1-4-23-24-16-22(6-7-28(24)39-34-25(23)18-44-29(34)17-27-26(35(44)47)19-51-36(48)38(27,50)5-2)52-37(49)43-15-14-42(30-20-53-54-21-31(30)43)33(46)9-8-32(45)41-12-10-40(3)11-13-41/h6-7,16-17,30-31,50H,4-5,8-15,18-21H2,1-3H3/t30?,31?,38-/m0/s1.
What are the key properties of [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate?
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate has a molecular weight of 776.94 g/mol, XLogP of 2.97, 6 rotatable bonds, 1 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 1-[4-(4-methylpiperazin-1-yl)-4-oxobutanoyl]-2,3,4a,5,8,8a-hexahydrodithiino[4,5-b]pyrazine-4-carboxylate is sourced from PubChem (CID 174296618), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).